David W. Cheng MD, PhD

Associate Professor of Diagnostic Radiology

Specialties & Subspecialties

Cancer Center, Yale: Thoracic Oncology Program | Melanoma Program | Hematology Program

Diagnostic Radiology

Pediatric Thyroid Center

Education & Training

  • Ph.D., University of California at Los Angeles (1992)
  • M.D., Albert Einstein College of Medicine (1996)
  • Resident, Albert Einstein College of Medicine, Montefiore Medical Center, New York, NY , Internal Medicine (1996 - 1998)
  • Resident, Albert Einstein College of Medicine/Montefiore Medical Center, New York, NY , Nuclear Medicine (1998 - 2000)
  • Fellow, Memorial Sloan Kettering Cancer Center, New York, NY , Nuclear Medicine (2000 - 2001)

Patient Care

Accepts New Patients? Yes | Patient Type: Adult, Child | Accepts referrals from patients


Clinical Interests

Positron Emission Tomography (PET) imaging (including oncology and benign conditions); general nuclear medicine studies, including bone, gallium, leukocyte, Meta-Iodo-Benzyl-Guanidine (MIBG), octreotide, liver-spleen, renal, brain perfusion, lung ventilation and perfusion, GI bleed, Hydroxy Iminodiacetic Acid (HIDA), thyroid disease and cancer diagnostic studies; radioisotope therapies, including radioiodine for thyroid cancer, zevalin, samarium and octreotide


Cancers Treated

Cutaneous T-Cell Lymphoma, Lung, Lymphoma (Non-Hodgkin's), Thyroid


Clinical Trials

ConditionsStudy Title
Hyperparathyroidism and Hypophosphatemia, FamilialThe Role of Parathyroid Hormone in the Pathogenesis of Skeletal Disease in X-linked Hypophosphatemic Rickets
Healthy SubjectsPET Imaging of the Kappa Opioid Receptor in Humans
Diabetes Mellitus, Type 1PET Imaging of Beta-Cell Mass in Healthy and T1DM with 18F-FP-DTBZ and B/I Infusion
Alcohol DrinkingKappa-PET imaging and naltrexone in alcohol drinking behaviors
Major Depressive DisorderPET imaging of mGluR5 with drug challenge

More Clinical Trials...

Edit Profile